No abstract available
Keywords:
ACE2; angiotensin II receptor blocker; angiotensin‐converting enzyme inhibitor; coronavirus disease 2019; epidemiology; infectious diseases.
MeSH terms
-
Angiotensin Receptor Antagonists / adverse effects
-
Angiotensin Receptor Antagonists / pharmacology*
-
Angiotensin-Converting Enzyme 2
-
Angiotensin-Converting Enzyme Inhibitors / adverse effects
-
Angiotensin-Converting Enzyme Inhibitors / pharmacology*
-
Betacoronavirus / drug effects*
-
COVID-19
-
Cardiovascular Diseases* / complications
-
Cardiovascular Diseases* / drug therapy
-
Comorbidity
-
Coronavirus Infections / complications*
-
Coronavirus Infections / mortality
-
Disease Notification
-
Humans
-
Pandemics
-
Peptidyl-Dipeptidase A / drug effects
-
Peptidyl-Dipeptidase A / metabolism
-
Pneumonia, Viral / complications*
-
Pneumonia, Viral / mortality
-
Risk Factors
-
SARS-CoV-2
-
Severity of Illness Index
Substances
-
Angiotensin Receptor Antagonists
-
Angiotensin-Converting Enzyme Inhibitors
-
Peptidyl-Dipeptidase A
-
ACE2 protein, human
-
Angiotensin-Converting Enzyme 2